Santana, Bby Boy .
HRN: 22-55-35 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/29/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
01/29/2023
02/05/2023
IVTT
50mg
Q24
PSNB
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes